FIELD: medicine, medicinal technique, pharmacy. SUBSTANCE: invention relates to the use of sulfonamides of the general formula (I) 
as therapeutically active substances in central nervous system disorders and for preparing corresponding medicinal agents. Compounds of the formula (I) show the enhanced biological activity. EFFECT: valuable medicinal and biological properties of compounds. 19 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BENZENESULFONE DERIVATIVES AND MEDICINAL AGENT | 1999 |
|
RU2201922C2 |
| TRICYCLIC DICARBONYL DERIVATIVES AND DRUG BASED ON SAID | 1995 |
|
RU2145606C1 |
| IMIDAZODIAZEPINES, METHOD OF THEIR SYNTHESIS AND DRUG | 1995 |
|
RU2139873C1 |
| DERIVATIVES OF ARYL- AND HETEROARYLSULFONEAMIDES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1995 |
|
RU2163598C2 |
| INDOLE DERIVATIVES AND THEIR PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE SALTS, PHARMACEUTICAL PREPARATION ON SAID | 1994 |
|
RU2136662C1 |
| OXAZOLIDEN-1-ONE DERIVATIVES, AND DRUG BASED THEREON | 1994 |
|
RU2133743C1 |
| ARYLPYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2189976C2 |
| DERIVATIVES OF 5H-THIAZOL[3,2-A]PYRIMIDINE, INTERMEDIATE COMPOUNDS AND MEDICINAL AGENT | 1998 |
|
RU2197493C2 |
| NEW PYRROLOCARBAZOLES | 1995 |
|
RU2162089C2 |
| RETINOIC ACID X-RECEPTOR LIGANDS | 1995 |
|
RU2146241C1 |
